Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Return on Sales (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Return on Sales for 16 consecutive years, with 0.04% as the latest value for Q3 2025.

  • Quarterly Return on Sales rose 22.0% to 0.04% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Sep 2025, up 18.0% year-over-year, with the annual reading at 0.14% for FY2024, 13.0% down from the prior year.
  • Return on Sales for Q3 2025 was 0.04% at Xtant Medical Holdings, down from 0.1% in the prior quarter.
  • The five-year high for Return on Sales was 0.37% in Q3 2023, with the low at 0.22% in Q4 2023.
  • Average Return on Sales over 5 years is 0.08%, with a median of 0.12% recorded in 2023.
  • The sharpest move saw Return on Sales skyrocketed 53bps in 2023, then tumbled -55bps in 2024.
  • Over 5 years, Return on Sales stood at 0.17% in 2021, then grew by 15bps to 0.14% in 2022, then plummeted by -53bps to 0.22% in 2023, then soared by 54bps to 0.1% in 2024, then surged by 139bps to 0.04% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 0.04%, 0.1%, and 0.0% for Q3 2025, Q2 2025, and Q1 2025 respectively.